Prominent role of liver in elevated plasma palmitoleate levels in response to rosiglitazone in mice fed high-fat diet

Journal of Physiology and Pharmacology

Volumn 60, Issue 4, 2009, Pages 135-140

  Kuda, O ^a   Stankova, B ^b   Tvrzicka, E ^b   Hensler, M ^a   Jelenik, T ^a   Rossmeisl, M ^a   Flachs, P ^a   Kopecky, J ^a  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Hepatic lipogenesis; Insulin resistance; Palmitoleic acid; Stearoyl CoA desaturase; Thiazolidinediones

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; CORN OIL; PALMITOLEIC ACID; ROSIGLITAZONE;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; LIPID COMPOSITION; LIPID DIET; LIPOGENESIS; LIVER LEVEL; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

ADIPOSE TISSUE, WHITE; ANIMALS; CORN OIL; DIETARY FATS; FATTY ACIDS; FATTY ACIDS, MONOUNSATURATED; GLUCOSE CLAMP TECHNIQUE; GLYCOGEN; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; LIPIDS; LIVER; MICE; MUSCLE, SKELETAL; OLEIC ACIDS; ORGAN SPECIFICITY; RANDOM ALLOCATION; STEAROYL-COA DESATURASE; THIAZOLIDINEDIONES; UP-REGULATION;

EID: 75749129893     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Vessby B, Gustafsson IB, Tengblad S, Boberg M, Andersson A. Desaturation and elongation of fatty acids and insulin action. Ann N Y Acad Sci 2002; 967: 183-195.
2. Cao H, Gerhold K, Mayers JR, Wiest MM, Watkins SM, Hotamisligil GS. Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell 2008; 134: 933-944.
3. Paton CM, Ntambi JM. Biochemical and physiological function of stearoyl-CoA desaturase. Am J Physiol Endocrinol Metab 2009; 297(1): E28-E37.
4. Riserus U, Tan GD, Fielding BA, Neville, et al. Rosiglitazone increases indexes of stearoyl-CoA desaturase activity in humans: link to insulin sensitization and the role of dominant-negative mutation in peroxisome proliferatoractivated receptor-gamma. Diabetes 2005; 54: 1379-1384.
5. Kolak M, Yki-Jarvinen H, Kannisto K, et al. Effects of chronic rosiglitazone therapy on gene expression in human adipose tissue in vivo in patients with type 2 diabetes. J Clin Endocrinol Metab 2007; 92: 720-424.
6. Yao-Borengasser A, Rassouli N, Varma V, et al. Stearoyl-CoA desaturase 1 (SCD1) gene expression increases following pioglitazone treatment and is associated with PPAR-gamma responsiveness. J Clin Endocrinol Metab 2008; 93: 4431-4439.
7. Toyama T, Kudo N, Hibino Y, Mitsumoto A, Nishikawa M, Kawashima Y. Effects of pioglitazone on stearoyl-CoA desaturase in obese Zucker fa/fa rats. J Pharmacol Sci 2007; 104: 137-145.
8. Wang Y, Jones VB, Urs S, et al. The human fatty acid synthase gene and de novo lipogenesis are coordinately regulated in human adipose tissue. J Nutr 2004; 134: 1032-1038.
9. Kuda O, Jelenik T, Jilkova Z, et al. n-3 fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed high-fat diet. Diabetologia 2009; 52: 941-951.
10. Tvrzicka E, Vecka M, Stankova B, Zak A. Analysis of fatty acids in plasma lipoproteins by gas chromatography-flame ionization detection. Quantitative aspects. Anal Chim Acta 2002; 465: 337-350.
11. Matsuzaka T, Shimano H, Yahagi N, et al. Crucial role of a long-chain fatty acid elongase, Elovl 6, in obesity-induced insulin resistance. Nat Med 2007; 13:1193-1202.
12. Stefan N, Peter A, Cegan A, et al. Low hepatic stearoyl-CoA desaturase 1 activity is associated with fatty liver and insulin resistance in obese humans. Diabetologia 2008; 51: 648-656.
13. Lessard SJ, Lo Giudice SL, Lau W, et al. Rosiglitazone enhances glucose tolerance by mechanisms other than reduction of fatty acid accumulation within skeletal muscle. Endocrinology 2004; 145: 5665-5670.
14. Miyazaki Y, DeFronzo RA. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients. Diabetes Obes Metab 2008; 10: 1204-1211.
15. Wierzbicki M, Chabowski A, Zendzian-Piotrowska M, Gorski J. Differential effects of in vivo PPARγ and α activation on fatty acid transport proteins expression and lipid content in rat liver. J Physiol Pharmacol 2009; 60: 99-106.
16. Zendzian-Piotrowska M, Baranowski M, Zabielski P, Gorski J. Effects of pioglitazone and high-fat diet on ceramide metabolism in rat skeletal muscles. J Physiol Pharmacol 2006; 57: 101-114.